Recent Finacing
Recent Raise
PeptiMimesis is a biopharmaceutical company that discovers and develops therapeutic transmembrane peptides via a proprietary platform targeting immuno-oncology and oncology targets, advancing a HER2 candidate for breast cancer brain metastases.
Focus Areas
Recent Investors
Total Raised
Funding rounds
Investor